Site

Search results

  1. UCSF public comment on FDA Listing of Ingredients in Tobacco Products – Revised Draft Guidance for Industry

    St. Helen, Eunice Neeley, Stanton A. Glantz University of California, San Francisco TCORS *Georgia ...

  2. FDA should regulate the manufacturing and marketing of hookah tobacco to prevent misperceptions of harm and widespread use

    University of California, San Francisco*   INTRODUCTION   Hookah smoking is an alternative form of tobacco ...

  3. RJ Reynold’s Unpublished Randomized Controlled Trial Finds that Camel Snus is Not Effective for Smoking Cessation

    Stanton A. Glantz, PhD Center for Tobacco Control Research and Education, University of California, San Francisco     RJ Reynolds’ Unpublished Study on Camel Snus Compared to Nicotine Replacement Therapy ...

  4. The “Continuum of Risk” Must Include Cardiovascular Disease

    and Carolyn Calfee, MD University of California, San Francisco   June 9, 2014   Most of the discussion ...

  5. The FDA should not adopt the nicotine “harm reduction” paradigm because doing so is likely to increase the amount of smoking-caused disease and death

    Lempert, JD, MPH, Gideon St.Helen, PhD, and Janice Tsoh, PhD University of California, San Francisco ...

  6. FDA should revise its new guidance on listing of ingredients in tobacco products to require disclosure of all ingredients that can become toxic during normal use

    Hendlin, PhD; Neal L. Benowitz, MD; Peyton Jacob, PhD; Stanton A. Glantz, PhD University of California San Francisco April 24, 2018 Docket No. FDA-2009-D-0524             FDA’s April 2018 revised guidance ...

  7. FDA’s proposed modifications to its compliance policy for e-cigarettes leaves millions of youth at risk for starting to use e-cigarettes; FDA needs to remove these products from the market now and clamp down on illegal therapeutic and modified risk claims

    relevant to San Francisco's recent decision to introduce a law prohibiting the sale of ecigs that have ...

  8. Dieter Meyerhoff, PhD

    Professor in Residence Professor Radiology [email protected] +1 415 221-4810 ext. 24803 Dieter Meyerhoff, PhD, is a Professor in Residence in the Department of Radiology at the University of California, San Francisco and at the San Francisco Veterans Affairs Medical Center. He is also Co-Director ...

  9. Swedish Match's revised MRTP application didn't adequately address FDA's questions; FDA should deny its application to make reduced risk claims

    MPH; Stanton A. Glantz, PhD   University of California San Francisco TCORS 1 Georgia State University ...

  10. Lawrence Green, DrPH, MPH

    Professor Emeritus Epidemiology & Biostatistics [email protected] +1 415 514-8115 Before joining the University of California, San Francisco in 2005, Professor Green was Director of the Office of Science and Extramural Research for CDC. He has been on the full-time public health and medical faculties ...

Pages